• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

SRp20外显子4剪接的调控

Regulation of SRp20 exon 4 splicing.

作者信息

Jumaa H, Nielsen P J

机构信息

Max Planck Institute for Immunobiology, Stuebeweg 51, D-79108, i. Br, Freiburg, Germany.

出版信息

Biochim Biophys Acta. 2000 Nov 15;1494(1-2):137-43. doi: 10.1016/s0167-4781(00)00233-5.

DOI:10.1016/s0167-4781(00)00233-5
PMID:11072076
Abstract

SR proteins are essential splicing factors involved in the use of both constitutive and alternative exons. We previously showed that the SR proteins SRp20 and ASF/SF2 have antagonistic activities on SRp20 pre-mRNA splicing. SRp20 activates exon 4 recognition in its pre-mRNA, whereas ASF/SF2 inhibits this recognition. In experiments aimed at testing the specificity of SRp20 and ASF/SF2 for exon 4 splicing regulation, we show here that this specificity lies in the RNA binding domains of SRp20 and ASF/SF2 and not in the RS domains. Surprisingly, a deletion of 14 amino acids at the end of ASF/SF2-RBD2 converts ASF/SF2 from an inhibitor to an activator of exon 4 splicing. We found that ASF3 also inhibits exon 4 recognition, thus acting similarly to ASF/SF2, while SC35 activates a cryptic 5' splice site downstream of exon 3 and, in doing so, represses exon 4 use. In contrast, Tra2 and the SR proteins 9G8 and SRp40 do not appear to affect exon 4 splicing.

摘要

SR蛋白是参与组成型外显子和可变外显子剪接的重要剪接因子。我们之前表明,SR蛋白SRp20和ASF/SF2对SRp20前体mRNA剪接具有拮抗活性。SRp20可激活其前体mRNA中外显子4的识别,而ASF/SF2则抑制这种识别。在旨在测试SRp20和ASF/SF2对外显子4剪接调控特异性的实验中,我们在此表明这种特异性存在于SRp20和ASF/SF2的RNA结合结构域中,而非RS结构域。令人惊讶的是,ASF/SF2-RBD2末端缺失14个氨基酸会使ASF/SF2从外显子4剪接的抑制剂转变为激活剂。我们发现ASF3也抑制外显子4的识别,因此其作用与ASF/SF2类似,而SC35激活外显子3下游的一个隐蔽5'剪接位点,这样做会抑制外显子4的使用。相比之下,Tra2以及SR蛋白9G8和SRp40似乎不影响外显子4的剪接。

相似文献

1
Regulation of SRp20 exon 4 splicing.SRp20外显子4剪接的调控
Biochim Biophys Acta. 2000 Nov 15;1494(1-2):137-43. doi: 10.1016/s0167-4781(00)00233-5.
2
The splicing factor SRp20 modifies splicing of its own mRNA and ASF/SF2 antagonizes this regulation.剪接因子SRp20可修饰其自身mRNA的剪接,而ASF/SF2可拮抗这种调控作用。
EMBO J. 1997 Aug 15;16(16):5077-85. doi: 10.1093/emboj/16.16.5077.
3
Human splicing factor ASF/SF2 encodes for a repressor domain required for its inhibitory activity on pre-mRNA splicing.人类剪接因子ASF/SF2编码一个对前体mRNA剪接具有抑制活性所需的阻遏结构域。
J Biol Chem. 2002 Apr 12;277(15):12579-86. doi: 10.1074/jbc.M107867200. Epub 2002 Jan 18.
4
The second RNA-binding domain of the human splicing factor ASF/SF2 is the critical domain controlling adenovirus E1A alternative 5'-splice site selection.人类剪接因子ASF/SF2的第二个RNA结合结构域是控制腺病毒E1A 5'端可变剪接位点选择的关键结构域。
Biochem J. 2004 Jul 15;381(Pt 2):343-50. doi: 10.1042/BJ20040408.
5
The CD44 alternative v9 exon contains a splicing enhancer responsive to the SR proteins 9G8, ASF/SF2, and SRp20.CD44可变v9外显子包含一个对SR蛋白9G8、ASF/SF2和SRp20有反应的剪接增强子。
J Biol Chem. 2003 Aug 29;278(35):32943-53. doi: 10.1074/jbc.M301090200. Epub 2003 Jun 24.
6
hnRNP A1 and the SR proteins ASF/SF2 and SC35 have antagonistic functions in splicing of beta-tropomyosin exon 6B.异质性核糖核蛋白A1以及丝氨酸/精氨酸富含蛋白ASF/SF2和SC35在β-原肌球蛋白外显子6B的剪接过程中具有拮抗作用。
J Biol Chem. 2004 Sep 10;279(37):38249-59. doi: 10.1074/jbc.M405377200. Epub 2004 Jun 18.
7
The SR splicing factors ASF/SF2 and SC35 have antagonistic effects on intronic enhancer-dependent splicing of the beta-tropomyosin alternative exon 6A.SR剪接因子ASF/SF2和SC35对β-原肌球蛋白可变外显子6A的内含子增强子依赖性剪接具有拮抗作用。
EMBO J. 1997 Apr 1;16(7):1772-84. doi: 10.1093/emboj/16.7.1772.
8
Overexpression of the SR proteins ASF/SF2 and SC35 influences alternative splicing in vivo in diverse ways.SR蛋白ASF/SF2和SC35的过表达以多种方式影响体内的可变剪接。
RNA. 1995 May;1(3):335-46.
9
Tra2 beta, SF2/ASF and SRp30c modulate the function of an exonic splicing enhancer in exon 10 of tau pre-mRNA.Tra2β、SF2/ASF和SRp30c调节tau前体mRNA第10外显子中外显子剪接增强子的功能。
Genes Cells. 2004 Feb;9(2):121-30. doi: 10.1111/j.1356-9597.2004.00709.x.
10
The splicing factors 9G8 and SRp20 transactivate splicing through different and specific enhancers.剪接因子9G8和SRp20通过不同的特异性增强子激活剪接。
RNA. 1999 Mar;5(3):468-83. doi: 10.1017/s1355838299981967.

引用本文的文献

1
Alternative splicing modulates chromatin interactome and phase separation of the RIF1 C-terminal domain.可变剪接调节染色质相互作用组和RIF1 C末端结构域的相分离。
bioRxiv. 2024 Nov 1:2024.10.29.619708. doi: 10.1101/2024.10.29.619708.
2
Oncogenic SRSF3 in health and diseases.致癌性 SRSF3 在健康与疾病中的作用。
Int J Biol Sci. 2023 Jun 12;19(10):3057-3076. doi: 10.7150/ijbs.83368. eCollection 2023.
3
Use of CRISPR/Cas9 with homology-directed repair to silence the human topoisomerase IIα intron-19 5' splice site: Generation of etoposide resistance in human leukemia K562 cells.
使用具有同源定向修复功能的CRISPR/Cas9使人类拓扑异构酶IIα内含子19的5'剪接位点沉默:在人类白血病K562细胞中产生依托泊苷抗性。
PLoS One. 2022 May 26;17(5):e0265794. doi: 10.1371/journal.pone.0265794. eCollection 2022.
4
Biological function and molecular mechanism of SRSF3 in cancer and beyond.SRSF3在癌症及其他方面的生物学功能和分子机制。
Oncol Lett. 2022 Jan;23(1):21. doi: 10.3892/ol.2021.13139. Epub 2021 Nov 16.
5
Alternative RNA Splicing-The Trojan Horse of Cancer Cells in Chemotherapy.可变剪接——化疗中癌细胞的特洛伊木马。
Genes (Basel). 2021 Jul 18;12(7):1085. doi: 10.3390/genes12071085.
6
Aberrant expression and regulatory network of splicing factor-SRSF3 in tumors.肿瘤中剪接因子-SRSF3的异常表达及调控网络
J Cancer. 2020 Mar 15;11(12):3502-3511. doi: 10.7150/jca.42645. eCollection 2020.
7
Degradation of splicing factor SRSF3 contributes to progressive liver disease.剪接因子 SRSF3 的降解导致进行性肝病。
J Clin Invest. 2019 Aug 8;129(10):4477-4491. doi: 10.1172/JCI127374.
8
Auto-regulatory feedback by RNA-binding proteins.RNA 结合蛋白的自调节反馈。
J Mol Cell Biol. 2019 Oct 25;11(10):930-939. doi: 10.1093/jmcb/mjz043.
9
SRSF3 recruits DROSHA to the basal junction of primary microRNAs.SRSF3 将 DROSHA 募集到初级 microRNAs 的基础连接处。
RNA. 2018 Jul;24(7):892-898. doi: 10.1261/rna.065862.118. Epub 2018 Apr 3.
10
PTBP1 and PTBP2 impaired autoregulation of SRSF3 in cancer cells.PTBP1和PTBP2破坏了癌细胞中SRSF3的自身调节。
Sci Rep. 2015 Sep 29;5:14548. doi: 10.1038/srep14548.